Gradalis
Blood & Organ Banks · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2545 Golden Bear Dr Ste 110, Carrollton,...Phone Number
(214) 442-8100Website
www.gradalisinc.comRevenue
$8.7 MillionIndustry
About Gradalis
Gradalis is a late-stage biotechnology company dedicated to developing and commercializing personalized cancer immunotherapy solutions. Their flagship product, Vigil, is designed to harness the patient's immune system to target and eliminate cancer cells, showing promising results particularly in ovarian cancer. The company aims to provide innovative treatment options that can be used alone or alongside other therapies, with potential applications across various solid tumor types. Gradalis is focused on improving patient outcomes through personalized medicine.Explore more
Gradalis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Gradalis
Compare insights from companies similar to Gradalis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Gradalis Tech Stack
A closer look at the technologies used by Gradalis
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gradalis
Sign Up For FreeTo access detailed company insights
Gradalis is a late-stage biotechnology company dedicated to developing and commercializing personalized cancer immunotherapy solutions. Their flagship product, Vigil, is designed to harness the patient's immune system to target and eliminate cancer cells, showing promising results particularly in ovarian cancer. The company aims to provide innovati... Read More
